Benitec Biopharma Ownership | Who Owns Benitec Biopharma?
Benitec Biopharma Ownership Summary
Benitec Biopharma is owned by 23.95% institutional investors, 4.39% insiders, and 71.66% retail investors. Awm investment company is the largest institutional shareholder, holding 0% of BNTC shares. Franklin Biotechnology Discv A(acc)USD is the top mutual fund, with 8.29% of its assets in Benitec Biopharma shares.
BNTC Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Benitec Biopharma | 23.95% | 4.39% | 71.66% |
Sector | Healthcare Stocks | 49.65% | 8.78% | 41.57% |
Industry | Biotech Stocks | 46.85% | 8.74% | 44.40% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Awm investment company | - | - | - |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Awm investment company | - | - | - |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Awm investment company | - | - | -625.00K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Awm investment company | - | - | -625.00K |
Sold Out
Holder | Change |
---|---|
Awm investment company | -625.00K |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Jun 30, 2024 | 1 | - | 625,000 | - | 23 | - | 1 | - | - | - |
Sep 30, 2023 | 1 | -93.75% | 23 | -100.00% | - | 0.00% | - | -100.00% | 1 | -66.67% |
Jun 30, 2023 | 16 | -20.00% | 11,055,879 | -4.96% | 39 | 2.29% | 2 | -33.33% | 3 | -57.14% |
Mar 31, 2023 | 20 | -13.04% | 11,633,366 | -5.48% | 41 | 2.09% | 3 | -72.73% | 7 | 16.67% |
Dec 31, 2022 | 23 | 15.00% | 12,307,556 | -15.85% | 44 | 1.59% | 11 | -15.38% | 6 | 200.00% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Franklin Biotechnology Discv A(acc)USD | 1.64M | 8.29% | 1.42M |
Franklin Biotechnology Discovery A | 573.22K | 5.43% | - |
Vanguard Institutional Extnd Mkt Idx Tr | 201.22K | 1.02% | -6.57K |
Janus Henderson Hrzn Biotec E2 USD | 134.42K | 0.68% | 3.46K |
Simplify Health Care ETF | 89.87K | 0.45% | -26.67K |
Fidelity Extended Market Index | 49.07K | 0.25% | -5.21K |
BlackRock Extended Equity Market K | 18.50K | 0.18% | -8.00 |
NT Ext Equity Mkt Idx Fd - NL | 14.55K | 0.14% | - |
NT Ext Equity Mkt Idx Fd - DC - NL - T2 | 11.72K | 0.11% | 36.00 |
Northern Trust Extended Eq Market Idx | 9.77K | 0.09% | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Dec 03, 2024 | SUVRETTA CAPITAL MANAGEMENT, LLC | Buy | $46.18K | |
Dec 03, 2024 | SUVRETTA CAPITAL MANAGEMENT, LLC | Buy | $357.02K | |
Nov 19, 2024 | SUVRETTA CAPITAL MANAGEMENT, LLC | Buy | $15.28K | |
Nov 20, 2024 | SUVRETTA CAPITAL MANAGEMENT, LLC | Buy | $248.96K | |
Nov 19, 2024 | SUVRETTA CAPITAL MANAGEMENT, LLC | Buy | $120.94K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2024 Q4 | 6 | - |
2024 Q3 | - | - |
2024 Q2 | - | - |
2024 Q1 | - | - |
2023 Q4 | - | - |
BNTC Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools